Ebos Group
- Short interest
- 0.47%
- −0.15 pp 30d
- as of 8 Oct 2026
- Reported shorts
- 977.9K
- Shares on issue
- 209.054M
Ebos Group (EBO) Short Interest
Ebos Group (ASX:EBO) had 0.47% of shares reported as short positions as of 8 Oct 2026, representing 977,868 shares. Ebos Group operates in the Health Care Equipment & Services industry. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4About Ebos Group
EBOS Group is a diversified Australasian marketer, wholesaler, and distributor of healthcare, medical, and pharmaceutical products. The company operates across both the healthcare and animal care sectors, providing a broad range of products and services to meet the needs of its diverse customer base.
Company profile →Ebos Group (ASX:EBO) has 0.47% of its shares on issue reported as short positions as of 8 Oct 2026, or about 977,868 shares. Over the past 30 days that figure has fallen 0.15 percentage points, and over 90 days it has fallen 0.34 percentage points. Its highest recorded short interest was 0.83% in August 2026. EBO is classified in the Health Care Equipment & Services industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Short interest
History & FAQ →Weekly context: The 10 most shorted ASX stocks — Week 41, 2026.
Strategy fit
How each stock picker strategy reads EBO today
- Zanger BreakoutWatchScore 7rank 1797 of 1942
- CAN SLIMWatchScore 7rank 1345 of 1541
- Minervini Trend TemplateWatchScore 7rank 1492 of 1716
- Crowded-Short BreakoutWatchScore 20rank 330 of 1502
- Quality compoundersWatchScore 15rank 929 of 1669
Prices to 14 Oct 2026 · Mechanical readings of published rules, not recommendations · Not financial adviceFull strategy readings →
EBO fundamentals
In the year to 30 Jun 2026, Ebos Group (ASX:EBO) recorded revenue of A$13.5B and net profit after tax of A$225.2M. A year earlier it recorded revenue of A$12.3B and net profit after tax of A$215.1M. Year-on-year growth: revenue +9.9% (FY). Net margin 1.7% (FY). Figures are in AUD, the company's reporting currency; source: ASX (Markit), as at 14 Oct 2026.
Full statements, ratios and filings are on the Financials tab. Not financial advice.
Latest EBO news
All news- NZX Capital Change Notice - Options
asx · 11 Oct 2026
- NZX Capital Change Notice - Performance Rights
asx · 11 Oct 2026
- Notification regarding unquoted securities - EBO
asx · 11 Oct 2026
Company details
website
address
More Health Care Equipment & Services Stocks
Other shorted stocks in this sector
Be the first to discuss EBO
Start a research thread or post the first pulse update